Growth Metrics

Adient (ADNT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Adient (ADNT) over the last 11 years, with Q4 2025 value amounting to $855.0 million.

  • Adient's Cash & Equivalents fell 58.14% to $855.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $855.0 million, marking a year-over-year decrease of 58.14%. This contributed to the annual value of $958.0 million for FY2025, which is 137.57% up from last year.
  • According to the latest figures from Q4 2025, Adient's Cash & Equivalents is $855.0 million, which was down 58.14% from $958.0 million recorded in Q3 2025.
  • Adient's Cash & Equivalents' 5-year high stood at $2.1 billion during Q4 2021, with a 5-year trough of $754.0 million in Q1 2025.
  • Over the past 5 years, Adient's median Cash & Equivalents value was $926.5 million (recorded in 2023), while the average stood at $1.0 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 5668.27% in 2022, then soared by 1721.22% in 2023.
  • Over the past 5 years, Adient's Cash & Equivalents (Quarter) stood at $2.1 billion in 2021, then plummeted by 56.68% to $901.0 million in 2022, then rose by 9.88% to $990.0 million in 2023, then decreased by 13.13% to $860.0 million in 2024, then dropped by 0.58% to $855.0 million in 2025.
  • Its last three reported values are $855.0 million in Q4 2025, $958.0 million for Q3 2025, and $860.0 million during Q2 2025.